120 related articles for article (PubMed ID: 12585827)
1. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.
Shiratori Y; Shiina S; Teratani T; Imamura M; Obi S; Sato S; Koike Y; Yoshida H; Omata M
Ann Intern Med; 2003 Feb; 138(4):299-306. PubMed ID: 12585827
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.
Lo CM; Liu CL; Chan SC; Lam CM; Poon RT; Ng IO; Fan ST; Wong J
Ann Surg; 2007 Jun; 245(6):831-42. PubMed ID: 17522506
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action and treatment of type I interferon in hepatocellular carcinoma.
Peng C; Ye Z; Ju Y; Huang X; Zhan C; Wei K; Zhang Z
Clin Transl Oncol; 2024 Feb; 26(2):326-337. PubMed ID: 37402970
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma.
Fangazio S; Camatta D; Tran Minh M; Ceriani E; Minisini R; Pirisi M
J Hepatol; 2017 Sep; ():. PubMed ID: 28890357
[No Abstract] [Full Text] [Related]
5. Reply to: "Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma".
Prenner S; Kulik L
J Hepatol; 2017 Sep; ():. PubMed ID: 28918130
[No Abstract] [Full Text] [Related]
6. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions.
Li L; Li ZZ; Pan LX; Su JY; Huang S; Ma L; Zhong JH
J Clin Transl Hepatol; 2024 May; 12(5):525-533. PubMed ID: 38779519
[TBL] [Abstract][Full Text] [Related]
7. Advances in postoperative adjuvant therapy for primary liver cancer.
Zeng ZM; Mo N; Zeng J; Ma FC; Jiang YF; Huang HS; Liao XW; Zhu GZ; Ma J; Peng T
World J Gastrointest Oncol; 2022 Sep; 14(9):1604-1621. PubMed ID: 36187393
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer.
Kuromatsu R; Ide T; Okamura S; Noda Y; Kamachi N; Nakano M; Shirono T; Shimose S; Iwamoto H; Kuwahara R; Arinaga-Hino T; Niizeki T; Zaizen Y; Takaki H; Shirachi M; Koga H; Torimura T
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565424
[TBL] [Abstract][Full Text] [Related]
9. Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection.
Wu KC; Lee IC; Chi CT; Lei HJ; Chau GY; Yeh YC; Su CW; Huo TI; Chao Y; Lin HC; Hou MC; Huang YH
Am J Cancer Res; 2021; 11(11):5526-5542. PubMed ID: 34873477
[TBL] [Abstract][Full Text] [Related]
10. Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients.
Nirei K; Kanda T; Masuzaki R; Mizutani T; Moriyama M
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440967
[No Abstract] [Full Text] [Related]
11. Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC.
Gao X; Zhan M; Wang L; Ding Y; Niu J
J Hepatocell Carcinoma; 2020; 7():347-360. PubMed ID: 33299823
[TBL] [Abstract][Full Text] [Related]
12. Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma.
Ou Q; Yu Y; Li A; Chen J; Yu T; Xu X; Xie X; Chen Y; Lin D; Zeng Q; Zhang Y; Tang X; Yao H; Luo B
Ann Transl Med; 2020 Mar; 8(5):230. PubMed ID: 32309377
[TBL] [Abstract][Full Text] [Related]
13. Influence of Interferon-free Direct-acting Antiviral Therapy on Primary Hepatocellular Carcinoma Recurrence: A Landmark Time Analysis and Time-dependent Extended Cox Proportional Hazards Model Analysis.
Miuma S; Miyamoto J; Taura N; Fukushima M; Sasaki R; Haraguchi M; Shibata H; Sato S; Miyaaki H; Nakao K
Intern Med; 2020; 59(7):901-907. PubMed ID: 32238660
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response.
Sasaki R; Kanda T; Kato N; Yokosuka O; Moriyama M
World J Hepatol; 2018 Dec; 10(12):898-906. PubMed ID: 30631394
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.
Koda M; Tanaka S; Takemura S; Shinkawa H; Kinoshita M; Hamano G; Ito T; Kawada N; Shibata T; Kubo S
Liver Cancer; 2018 Sep; 7(3):261-276. PubMed ID: 30319984
[TBL] [Abstract][Full Text] [Related]
16. Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response.
Kanda T; Matsuoka S; Moriyama M
Hepatol Int; 2018 Mar; 12(2):90-93. PubMed ID: 29619621
[No Abstract] [Full Text] [Related]
17. Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase.
Igbe I; Shen XF; Jiao W; Qiang Z; Deng T; Li S; Liu WL; Liu HW; Zhang GL; Wang F
Oncotarget; 2017 Dec; 8(69):113734-113748. PubMed ID: 29371942
[TBL] [Abstract][Full Text] [Related]
18. Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.
Funaki M; Kitabayashi J; Shimakami T; Nagata N; Sakai Y; Takegoshi K; Okada H; Murai K; Shirasaki T; Oyama T; Yamashita T; Ota T; Takuwa Y; Honda M; Kaneko S
Sci Rep; 2017 Dec; 7(1):16978. PubMed ID: 29208982
[TBL] [Abstract][Full Text] [Related]
19. Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data.
Huan HB; Wu LL; Lau WY; Wen XD; Zhang L; Yang DP; Wang XS; Bie P; Xia F
Oncotarget; 2017 Oct; 8(52):90291-90300. PubMed ID: 29163828
[TBL] [Abstract][Full Text] [Related]
20. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
